Biological Collection of Brain Tumors

Study Purpose

The objective of this study is to build a collection of biological samples from patients with brain tumors.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Unknown
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Patient whose diagnosis of brain tumor has been confirmed.
  • - Adult patients, from 18 years old and without upper age limit.
  • - Patient affiliated to a social security scheme or equivalent.
  • - Patient able to consent, having dated and signed an informed consent.

Exclusion Criteria:

  • - Pregnant or breastfeeding women.
  • - Patient under guardianship or curators.
- Persons deprived of their liberty by a judicial or administrative decision

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT05571579
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Hospices Civils de Lyon
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries France
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Brain Tumor
Arms & Interventions

Arms

: brain tumors

Interventions

Biological: - blood and/or csf collection

blood and/or collection Only once : 1 tube of blood of 4 mL on dry tube with or without gel, 2 tubes of blood of 4 mL on EDTA tube, If CSF collected for diagnosis is available, it can be sent for storage in the collection.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Hospices Civils de Lyon, Bron, Rhône, France

Status

Recruiting

Address

Hospices Civils de Lyon

Bron, Rhône, 69500

Site Contact

François Ducray, Pr

[email protected]

04 72 68 13 21 #+33

Stay Informed & Connected